Hugo de la Peña
Cancer Research International
MESSAGE FROM THE PRESIDENT
Cancer affects us all, rich, poor, from all countries, colours and ages,
there is no discrimination whatsoever. The statistics are not on our side.
Cancer is a leading cause of death worldwide. 1 in 500 children get some form of
cancer and that figure terrifies me as a parent. It gets worse, 1 in 3 adults
throughout the world contract cancer and that means that among those closest to
me (including myself) some of us will get cancer. Ironically the longer we live
the more tickets for this lottery we get. There are more than 200 types of
cancer and some of them we know nothing about.The good news is that because we know so much about the common forms, 1 in 4 people survive cancer. In fact we are so good curing some cancers that some people suffer for a second or third time in their lives and walking today we have people that have survived cancer more than once.
Here at Cancer Research International we are committed to improve survival rates, and therefore we have created collaborations with the best centers, universities and organizations in the world in order to make this happen. Today we are very proud to have gained the trust and partnership of Harvard, Baylor, Cambridge, Oxford, London, Barcelona, Paris, Edinburgh, Nottingham and others.
We are changing the future of Medicine forever because as yet, we are not at the pinnacle of our evolution.
Welcome to Cancer Research International
Dr. Hugo De La Peña
Click play to watch interview
ver
parte 2
The Mission of this project is very simple:
- Create the World’s Leading Centre in Cancer Treatment and
- Create the World’s Leading Centre in Cancer Research
Medical Doctor (MD):
1995-2002 Medical School (UAC) Torreón, Mexico.
Graduated 1st Place of the Class with the Highest Score and the maximum Double Honorary Mention:
Summa Cum Laude and Magna Cum Laude
2001-2002 Study Coordinator and Clinical Consultant of the first two Clinical Trials in Human Cancer Gene Therapy undertaken in Latin America.
Post Grade Department.
UANL, Monterrey, NL, Mexico.
PhD in Philosophy:
2002-2006 University College London (UCL), Anthony Nolan Research Institute, London, UK. Cancer Immunotherapy and Immunogenetics. Winner of the “Young Scientist Award” in the UK, 2004
Postdoctoral Scientist:
2007-2009 University of Cambridge, (Downing College) Cambridge, England, UK. Tolerance and Autoimmunity.
2010: Young Scientist Award, European Society for Cancer Research
1995-2002 Medical School (UAC) Torreón, Mexico.
Graduated 1st Place of the Class with the Highest Score and the maximum Double Honorary Mention:
Summa Cum Laude and Magna Cum Laude
2001-2002 Study Coordinator and Clinical Consultant of the first two Clinical Trials in Human Cancer Gene Therapy undertaken in Latin America.
Post Grade Department.
UANL, Monterrey, NL, Mexico.
PhD in Philosophy:
2002-2006 University College London (UCL), Anthony Nolan Research Institute, London, UK. Cancer Immunotherapy and Immunogenetics. Winner of the “Young Scientist Award” in the UK, 2004
Postdoctoral Scientist:
2007-2009 University of Cambridge, (Downing College) Cambridge, England, UK. Tolerance and Autoimmunity.
2010: Young Scientist Award, European Society for Cancer Research
Contacts
If you would like more information because:
info@cancerint.org
- You or a loved one live with cancer
- You or a loved one have been affected by cancer
- You would like to become an Honorary Member
- You would like to raise or donate money
- You would simply like more information
info@cancerint.org
No hay comentarios:
Publicar un comentario